Upcoming Supreme Court hearing on overturning Roe v. Wade, focusing on mifepristone access restrictions and FDA regulations.
Doubts raised whether judges and courts are better qualified than the NDA to administrate pills such as mifepristone.
Following oral arguments presented on Tuesday, the U.S. Supreme Court looked poised to rebuff a legal challenge to women's ...
The FDA and some health care groups had been worried that limits on the chemical could disrupt the medical supply chain.
A challenge to the FDA's regulation of the abortion pill mifepristone will be heard by the Supreme Court on Tuesday ...
On March 5, 2024, the US Food & Drug Administration (FDA) released final guidance titled “Dietary Supplements: New Dietary Ingredient Notification Procedures and Timeframes: Guidance for Industry.” ...
A majority of Supreme Court justices appeared skeptical Tuesday of the idea of a nationwide ban or new limits on mifepristone ...
U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans' access to the abortion pill mifepristone, in ...
Capitol Police on Tuesday morning arrested 13 protesters who were demonstrating against the Supreme Court's examination of ...
Initiated by the Texas-based Alliance for Hippocratic Medicine against the FDA’s policies, the dispute highlights significant ...
Supreme Court justices seemed concerned about whether abortion opponents have the right to sue over mifepristone.
The chaos around abortion care access continues to swirl, and the latest development in a post-Roe world is no exception: ...